Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 96-104

  Magal, Sharon Shnitman ^a   Jackman, Anna ^a   Pei, Xu Fang ^b   Schlegel, Richard ^c   Sherman, Levana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b EAST CAROLINA UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; APOPTOSIS; ARTICLE; GENE EXPRESSION REGULATION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ULTRAVIOLET C RADIATION; ULTRAVIOLET IRRADIATION;

ALLELES; APOPTOSIS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; DNA, NEOPLASM; GENES, P53; HUMANS; KERATINOCYTES; MUTATION; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0032484553     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<96::AID-IJC15>3.0.CO;2-B     Document Type: Article

References (41)

1. BOUNAMP, P., PELRUSSENSKY, R.T., BREIIKRANTZ, D., HONSG, J. MARKHAM, A. And FUSTNIG, N.K., Normal keratinization in spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol., 106, 761-771 (1988).
2. BRISIOW, R.G., JANG, A., PEACOCK, J., CHUNG, S. BLSCHIMOL, S. and HILL, R.P., Mutant p53 increases radioresistancc in rat embryo tibroblast simultaneously transfected with HPVI6 E7 and/or activated H-ras. Oncogene, 9, 1527-1536 (1994).
3. BUTZ, K., SHAHABEDDIN, L., GEISEN, C., SPITKOVSKY, D., ULLMANN, A. and HOPPE-SEYLER, F., Functional p53 protein in human papillomauruspositive cancer cells. Oncogene. 10, 927-936 (1995).
4. CAELLES, C., HELMBERG, A. and KARIN, M., p53-dependent apoptosis in tin absence of transcriptional activation of p53 target genes. Nature (Lond.), 370, 220-223 (1994).
5. CROOK, T. and VOUSDEN, K.H., Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanism of metastasis and involvement of environmental carcinogens, EMBO J., 11, 3935-3941 (1992).
6. DARZYNKIEWICZ, Z, BRUNO, S., DEL, BINO, G., GORCZYCA, W., HOTZ, M.A. LASSOTA, P. and TRAGANOS, K. Features of apoptotic cells measured by flow cytometry. Cytometry. 13, 795 -808 (1992).
7. PATTO, M.B., LI, Y., PANUS, J.F., HOWE, D.J., XIONG, Y. and WANG, X.-F., Transforming growth factor β induces the cycline-dependent kinase inhibitor p2l through a pS3-independent mechanism. Proc. nat. Acad. Sci. (Wash.), 92, 5545-5549 (1995).
8. DEMERS, G.W., FOSTER, S.A., HALBERT, C.L. and GALLOWAY, D.A., Crowth arrest by induction of p53 in DNA damaged Keratiniocytes is by passed by human papillomavirus 16 F:7. Proc. nat. Acad. Sci. (Wash.), 91, 4382-4386 (1994).
9. DYSON, N., HOWLEY, P.M., MUNGER, K. and HARLOW, H., The humaN papillomavirus In E7 oncoprotein is able to bind the retinoblastoma gent product. SCIENCE. 243, 934-937 (1989).
10. 1 arrest and apoptosis. Cancer Res., 54, 1169-1174 (1994).
11. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.F., LEVY, D.B., PARSONS, R. TRENT, J.M., LIN, D., MERCER, W.F.,. KINZLER, K.W. and VOGELSTEIN, B. WAFI a potential mediator of p53 tumor suppression. Cell. 75, 817-82 (1993).
12. GARTENHAUS, R.B., WANG, P. and HOFFMANS, P., Induction of the WAFI CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53 independent pathway. Proc. nat. Acad. Sci. (Waash.), 93, 265-268 (1996).
13. GUJULVA, C.N., BAEK, J.-H., SHIN, K.-H., CHERRICK, H.M. and PARK N.-H., Effect of UV irradiation on cell cycle viability and expression of p53 gaDd 153 and gadd 45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogtne, 9, 1819-1827 (1994).
14. HAAS-KOGAN, D., KOGAN, S.C., LEVI, D., DAZIN, P., TANG, A., FUNG, Y.-K.T. and ISRAEL, M.A., Inhibition of apopuisis by the retinoblastomu gene product. EMBO J., 14, 461-472 (1995).
15. 1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
16. HAUPT, Y., ROWAN, S., SHAULIAN, E., VOUSDEN, K. and OREN, M., Induction of apoptosis in HeLa cells by transactivation deficient p53. Genes Develop., 9, 2170-2183 (1995).
17. JOHNSON, H., DIMITROV, D., VOJTA, P.J., BARKET, J.C. NOUA, A., PI-RKIKASMITH, O.M. and SMITH, J.R., Evidence for a p53-independent pathway for upregulation of SD11 CIP1/WAF1/p21 RNA in human cells. Mol. Carcinogenesis, 11, 59-64 (1994).
18. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VCGELSTEIN, B. and CRAIC;. R.W., Participation of p53 in the cellular response to DNA damage Cancer Res., 51, 6304-6311 (1991).
19. KESSIS, D.T., SLEBOS, R.J., NELSON, W.G., KASTAN, M.B., PLUNKETT, B.S., MAN, S.M., LORINCZ, A.T., HENDRICK, L., and CUO, K.K., Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. nat. Acad. Sci., (Wash.), 90, 3988-3992 (1993).
20. KUERBITZ, S.J., PLUNKETI, B.S., WALSH, W.V. and KASTAN, M.B., Wild type p53 is a cell cycle checkpoint determinant following irradiation, Proc. nat. Acad. Sci. (Wash.), 89, 7491-7495 (1992).
21. LIHMAN, L.A., MODALL, R., BOKAMP, P., STANENK, J., BENNET, W.P., WEISH, J.A., MI. R.A., STAMPER, M.R. and HARRIS, C.C., p53 mutations in huinan immortalized epithelial cell linos carciongenesis 14, 833-839 (1993).
22. LOW, S.W., RULEY H.E. JACKS T. and HOUSMAN, D.h., p53-dopeiulonl apoploxis modulate the cytotoxicty of anticancor drugs. cell, 74, 957-967 (1993a)
23. LOWE, S.W., SCHMITI, F.M., SMITH, S.W., OSHORSI,. H.A. anil JACKS. T., p53 is required for radiation induced apoptosis in mouse thymocytes. Nature (Lond.), 362, 847-849 (1993b).
24. MILLER, D. and ROSMAN, G.J., Improved Rretrovialvectors for gene transfer and expression. BioTechniques 7, 980-988 (1989).
25. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKA, M., WANG, H.G., H.K. U.K., LFIBERMANN, D.A., HOFFMAN, B. and REED, J.C., Tumor suppressor p53 is a regulator of bel2 and bax gene expression in vitro Oncogene 9, 1793-1805 (1994).
26. MIYASHITA, T. and REED, J.C., Tumor suppressor pS3 is a direct transcriptional activator of human bax gene. Cell, 80, 293-291 (1995).
27. PAN, H. and GRIEP, A.E., Altered cell cycle regulation in the lens of HPV Id E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Develop. 8, 1285-1299 (1994).
28. SHERMAN, L., and SCHLEGEL., R., Serum and calcium-induced differentiation of human keratinocytes is inhibited by the 1:6 oncoprotein of human papillomavirus type 16, J. Virol., 70, 3269-3279 (1996).
29. SLEBOS, R.J.C., LEE., M.H., PLUNKETT, B.S., KESSIS, T.D., WILLIAMS. B.O., JACKS. T., HEDKICK, I.,. KASTAN. M.B. and Cho, K.R., p53-dependent C, arrest involves Rh related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. nat. Acad. Sci. (Wash.), 91, 5320-5324 (1994).
30. STEllER, M.A., ZOU, Z., SCHILLER, J.T. and BASERGA, R., Transformation by human papillomavirus 16116 and 1:7: role of the insulin-like growth factor I receptor. Cancer Res., 56, 5087-5091 (1996).
31. STRASSER, A., HARRIS. A.W., JACKS. T. and CORY, S., DNA damage can induce apoplosis in proliferating lymphoid cells via pA3-independent mechanism inhibitablc by bc12. Cell. 79, 329-339 (1994),
32. THOMAS. A., EL ROUBY. S., REED. J.C., KRAJKWSKI. S., SILBER, R., POTMSILM, M. and NEWCOMB, L.W., Drug induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between Oncogene mutation and bc12/bax proteins in drug resistance. Oncogene, 12, 1055-1062 (1996).
33. TSANCI, N.-M., NACIASAWA. H., LI, C. and LITTLE, J.B., Abrogation of p53 function by transfeclion of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene 10, 2403-2409 (1995),
34. WAGNER, A.J., KOKOSTIS. J.M. and HAY. N,. Myc mediated apoptosis requires wild type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 WAF1/CCP1. Gene Develop., 8, 2817-2830 (1994).
35. WERNESS, B.A., LEVINE, A.J. and HOWLEY, P.M., Association of human papillomavirus types 18 and 16 K6 proteins with p53. Science. 248, 76-79 (1990).
36. WHITE, A.K., LIVANOS. K.M. and TLSTY. T., Differential disruption of genomic integrity and cell cycle regulation in normal human fibrohlasts by HPV oncoproteins. Gene Develop., 8, 666-677 (1994).
37. WHITE, E., Life death and the pursuit of apoptosis. Genen Develop., 10, 1-15 (1996).
38. WYLLIE, A.H., Cell death: the significance of apoptosis, Int. Rev. Cytol., 68, 251-306(1980).
39. XIONGO, Y,. HANNON. G.J., ZHANG, H., CASSO. D., KOHAYASHI. R. and BLEACH, D., p2l is a universal inhibitor of cycline kinases. Nature (Lond.), 366, 701-704 (1993).
40. XC. G., MEIKRANTZ, W., SCHLEGEL, R. and SAGER. R., The human papilloma virus 16 DNA gene sensitzes human mammary epithelial cells to apoptosis induced by DNA damage. Proc. nat. Aaid. Sci. (Wash), 92, 7829-7833 (1995).
41. ZUR HAUSEN, H., Molecular pathogencsis of cancer of the cervix and ils causation by specific HPV types. Curr. Top. Microbiol. Inmunol., 186, 131-156 (1994).